Login
Toggle navigation
Videos
Categories
Trending
Let's Talk About Your Organization's Retirement Plan | Rene Bruner - Advisor of smith bruer advisors
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Rene Bruner is the CFP and Advisor of smith bruer advisors
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Journeying through Sun Life: A Conversation on Legacy, Evolution, and Future Strategies | Kevin Strain, CEO , Sun Life Financial.
00:10:00
Night of Sciences' at X-FAB Erfurt | Manfred Riemer, CEO, X Fab Silicon Foundries EVXFAB:PAR
00:10:00
Focus most of my time investing through Convective in Firetech companies preventing, suppressing or helping us adapt to wildfire|Bill Clerico,Managing Partner, Convective Capital
00:10:00
Interactive Brokers Chairman discusses the company's Q2 earnings beat.
00:10:00
$1.15 billion stake in its company to Sequoia and Paradigm in January 2022|Alfred Lin,Investor, Sequoia
00:10:00
Staying Safe Online: Cybersecurity Tips for 2021 | Nicole Sullivan - Co-Founder and Financial Planner, Prism Planning Partners | Ron Bernstein - Financial Planner, Prism Planning Partners
00:10:00
TJ Rodgers: Capitalism, Environmentalism, and Corporate Responsibility|T. J. Rodgers
00:10:00
Daetwyler Swisstec - DRUPA 2016 | Volker Cwielong, CEO, Daetwyler Holding AG31D1:FRA
00:10:00
Funding a 529 Plan: Smart Strategies for Your Child's Education | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Introducing Junior Mining Hub: A Resource for Tracking Mineral Exploration and Market Events
00:10:00
Holistic Financial Planning with Nikolski Financial: A Commitment to Your Future
00:10:00
Assessing Energy Challenges and Climate Solutions | John Doerr, Chairman, Kleiner Perkins.